ABU DHABI, UAE, May 14, 2024 /PRNewswire/ -- The Department of
Health – Abu Dhabi (DoH), the
regulator of the healthcare sector in the Emirate, has signed a
Memorandum of Understanding (MoU) with GSK, a leading biopharma
company, during Abu Dhabi Global Healthcare Week (ADGHW) to
establish a regional vaccine distribution hub in Abu Dhabi.
In the presence of Edward Hobart,
Ambassador of the United Kingdom
of Great Britain and Northern Ireland to the UAE, H.E.
Mansoor Al Mansoori, Chairman of
DoH, and Sir Jonathan Symonds,
Chairman of the GSK Board, the MoU was signed by H.E. Dr.
Noura Al Ghaithi, Undersecretary of
DoH and Boyd Chongphaisal, Vice President and General Manager, GSK
Gulf.
The key pillars of the collaboration are: the establishment of a
regional vaccine distribution hub in Abu
Dhabi; working together to maximise the strategic and
healthcare impacts of the establishment of the GSK Vaccine Regional
Distribution Hub; collaborating to ensure its successful
establishment and operation; and exploration of opportunities to
foster knowledge exchange and capability building through
collaboration between GSK and the UAE; and jointly focusing on
prevention strategies to address public health challenges.
Her Excellency Dr. Noura Khamis Al
Ghaithi, Undersecretary of the Department of Health –
Abu Dhabi (DoH), said:
"Thanks to Abu Dhabi's close-knit
community, diverse population, and continued investments in
healthcare infrastructure, the city is ideally equipped to help
make access to quality, responsible innovative healthcare a reality
for all. Reinforcing Abu Dhabi's position as a leading destination
for health life-science, the Department's collaboration with GSK
reinforces Abu Dhabi's commitment
to enhancing healthcare services, ensuring drug and vaccine
security, and fostering resilience in the healthcare sector. By
cultivating partnerships on the global stage, Abu Dhabi has earned a catalyst role in
strategically mapping the future trajectory of the healthcare
industry, focusing on improving patient outcomes, strengthening
healthcare systems, and promoting equitable access to essential
medicines and vaccines. This collaboration underscores our
dedication to fostering innovation, technological advancement, and
sustainability in the healthcare sector, ultimately contributing to
the well-being of our local population and those in need around the
world."
Boyd Chongphaisal, Vice President and General Manager, GSK
Gulf, said: "As a global biopharma company, GSK is dedicated to
developing transformational vaccines and medicines. With a focus on
driving innovation, we aim to positively impact millions of lives
across the Gulf countries through strategic partnerships. Through
establishing a regional vaccines distribution hub in Abu Dhabi, we will be able to meet the
increasing demand for GSK vaccines in the region, Near East and
South Asian countries, advancing healthcare standards and
addressing public health challenges."
This strategic approach emphasises the critical role of robust
immunisation programmes in addressing the evolving healthcare
landscape. As the UAE navigates demographic shifts, prevention
emerges as a core principle driving these strategies.
Held under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown
Prince of Abu Dhabi and Chairman
of Abu Dhabi Executive Council, Abu Dhabi Global Healthcare Week is
a major government initiative taking place between 13 and
15 May 2024.
For more information please visit: https://www.adghw.com/
About Department of Health – Abu
Dhabi (DoH):
The DoH is the regulatory body of the healthcare sector at the
Emirate of Abu Dhabi and ensures
excellence in healthcare by monitoring the health status of the
population. DoH defines the strategy for the health system,
monitors and analyses the health status of the population and
performance of the system. In addition, DoH shapes the regulatory
framework for the health system, inspects against regulations,
enforce standards, and encourages adoption of world-class best
practices and performance targets by all healthcare service
providers in the Emirate. DoH also drives programmes to increase
awareness and adoption of healthy living standards among the
residents of the Emirate of Abu
Dhabi in addition to regulating scope of services, premiums
and reimbursement rates of the health system.
For further information on DoH,
visit https://www.doh.gov.ae/ and follow on
X, Instagram, Facebook, LinkedIn
and YouTube.
About GSK:
GSK is a global biopharma company with a purpose to unite
science, technology, and talent to get ahead of disease together.
Find out more at gsk.com.
Photo -
https://mma.prnewswire.com/media/2412467/DoH_GSK_Vaccine.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/department-of-health--abu-dhabi-partners-with-gsk-to-establish-regional-vaccine-distribution-hub-302145053.html